Skip to the content

pharmaceutical daily

Pharmaceuticals, Biotechnology and Life Sciences

  • HOME
  • Pharma Business
  • About us
    • Media Kit
    • Privacy Policy
  • Contact
March 25, 2019 Off

AVROBIO, Inc. Reports Fourth Quarter and Fiscal Year 2018 Financial Results and Provides Business Update

By BusinessWire

Recruitment completed in investigator-sponsored Phase 1 Fabry study Phase 1 and Phase 2 clinical data updates for AVR-RD-01 in Fabry…

March 25, 2019 Off

Bristol-Myers Squibb Board of Directors Sends Letter to Shareholders Highlighting the Compelling Strategic and Financial Rationale of the Celgene Transaction; Company Provides Additional Investor Materials

By BusinessWire

Urges Shareholders to Vote “FOR” the Proposed Transaction on the WHITE Proxy Card NEW YORK–(BUSINESS WIRE)–Bristol-Myers Squibb Company’s (NYSE:BMY) Board…

March 25, 2019 Off

Aerie Pharmaceuticals Announces Four Appointments

By BusinessWire

DURHAM, N.C.–(BUSINESS WIRE)–Aerie Pharmaceuticals, Inc. (NASDAQ:AERI), an ophthalmic pharmaceutical company focused on the discovery, development and commercialization of first-in-class therapies…

March 25, 2019 Off

Global Animal Biotechnology Technologies, Markets and Companies Research Report 2019 – ResearchAndMarkets.com

By BusinessWire

DUBLIN–(BUSINESS WIRE)–The “Animal Biotechnology – Technologies, Markets and Companies” report from Jain PharmaBiotech has been added to ResearchAndMarkets.com’s offering. This…

March 25, 2019 Off

HitGen and Almirall Enter DNA-Encoded Library Based Innovative Drug Discovery Research Collaboration

By BusinessWire

CHENGDU, China–(BUSINESS WIRE)–HitGen Ltd announced that the company has entered into a research collaboration with Almirall to identify novel small…

Inflazome Receives Funding from The Michael J. Fox Foundation for Parkinson’s Research
March 25, 2019 Off

Inflazome Receives Funding from The Michael J. Fox Foundation for Parkinson’s Research

By BusinessWire

Funding in excess of US$1 million to support the development of a brain imaging probe for patient diagnosis and the…

March 25, 2019 Off

Axcella Appoints Shreeram Aradhye, M.B.B.S., M.D., as Executive Vice President, Chief Development Officer

By BusinessWire

CAMBRIDGE, Mass.–(BUSINESS WIRE)—-Axcella Health, a biotechnology company pioneering the research and development of novel multifactorial interventions to address dysregulated metabolism…

City of Hope Study Finds Popular Diabetes Diagnosis Test Misses Most Cases
March 23, 2019 Off

City of Hope Study Finds Popular Diabetes Diagnosis Test Misses Most Cases

By BusinessWire

The study was presented at ENDO 2019, Endocrine Society’s annual meeting DUARTE, Calif.–(BUSINESS WIRE)–lt;a href=”https://twitter.com/hashtag/CityofHope?src=hash” target=”_blank”gt;#CityofHopelt;/agt;–The hemoglobin A1c blood test…

Gossamer Bio Announces 2018 Annual Financial Results
March 22, 2019 Off

Gossamer Bio Announces 2018 Annual Financial Results

By BusinessWire

SAN DIEGO–(BUSINESS WIRE)–Gossamer Bio, Inc. (Nasdaq:GOSS), a clinical-stage biopharmaceutical company focused on discovering, acquiring, developing and commercializing therapeutics in the…

Teva Announces Launch of a Generic Version of EXJADE® (deferasirox) Tablets For Oral Suspension in the United States
March 22, 2019 Off

Teva Announces Launch of a Generic Version of EXJADE® (deferasirox) Tablets For Oral Suspension in the United States

By BusinessWire

JERUSALEM–(BUSINESS WIRE)–Teva Pharmaceutical Industries Ltd., (NYSE and TASE: TEVA) today announced the launch of a generic version of EXJADE®1 (deferasirox)…

Posts pagination

Previous 1 … 3,337 3,338 3,339 … 3,606 Next

JOIN OUR COMMUNITY

Proudly powered by WordPress | Theme: Envo Magazine